Health Care [ 12/12 ] | Health Care Equipment & Supplies [ 44/74 ]
NASDAQ | Common Stock
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.
The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting.
It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus.
In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings.
The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 8, 24 | -0.14 Increased by +54.84% | -0.34 Increased by +58.82% |
| May 9, 24 | -0.31 Decreased by -55.00% | -0.21 Decreased by -47.62% |
| Mar 14, 24 | -0.50 Increased by +26.47% | -0.20 Decreased by -150.00% |
| Nov 9, 23 | -0.20 Decreased by -400.00% | -0.29 Increased by +31.03% |
| Aug 10, 23 | -0.31 Decreased by -287.50% | -0.24 Decreased by -29.17% |
| May 11, 23 | -0.20 Decreased by -158.82% | -0.22 Increased by +9.09% |
| Mar 16, 23 | -0.68 Decreased by -372.00% | -0.15 Decreased by -353.33% |
| Nov 10, 22 | -0.04 Decreased by -110.53% | -0.04 |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 641.14 K Decreased by -73.91% | -9.70 M Decreased by -62.09% | Decreased by -1.51 K% Decreased by -521.19% |
| Jun 30, 24 | 161.10 K Decreased by -18.56% | -7.60 M Increased by +14.79% | Decreased by -4.72 K% Decreased by -4.62% |
| Mar 31, 24 | 252.75 K Decreased by -58.01% | -9.31 M Decreased by -61.80% | Decreased by -3.68 K% Decreased by -285.35% |
| Dec 31, 23 | 3.56 M Increased by +153.67% | -14.68 M Increased by +33.00% | Decreased by -412.82% Increased by +73.59% |
| Sep 30, 23 | 2.46 M Decreased by -51.77% | -5.98 M Decreased by -339.52% | Decreased by -243.47% Decreased by -811.29% |
| Jun 30, 23 | 197.81 K Decreased by -96.06% | -8.92 M Decreased by -232.01% | Decreased by -4.51 K% Decreased by -8.33 K% |
| Mar 31, 23 | 601.96 K Decreased by -97.35% | -5.76 M Decreased by -149.13% | Decreased by -956.11% Decreased by -1.95 K% |
| Dec 31, 22 | 1.40 M Decreased by -93.13% | -21.91 M Decreased by -392.13% | Decreased by -1.56 K% Decreased by -4.35 K% |